Potential benefits of delaying the second mRNA COVID-19 vaccine dose

no code implementations • 26 Feb 2021 • Benjamin F. Maier, Angelique Burdinski, Annika H. Rose, Frank Schlosser, David Hinrichs, Cornelia Betsch, Lars Korn, Philipp Sprengholz, Michael Meyer-Hermann, Tanmay Mitra, Karl Lauterbach, Dirk Brockmann

Using the situation and conditions in Germany as a reference system, we show that delaying the second vaccine dose is expected to prevent deaths in the four to five digit range, should the incidence resurge.

Inferring the effect of interventions on COVID-19 transmission networks

no code implementations • 7 Dec 2020 • Simon Syga, Diana David-Rus, Yannik Schälte, Michael Meyer-Hermann, Haralampos Hatzikirou, Andreas Deutsch

Countries around the world implement nonpharmaceutical interventions (NPIs) to mitigate the spread of COVID-19.

Clustering